Mediplantex National Pharmaceutical JSC (HNX:MED)

HNX:MED Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 3, 2025	Dec 31, 2024	Jan 1, 2024	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	280,466	322,660	335,070	260,610	187,775	244,924
Market Cap Growth	60.65%	-3.70%	28.57%	38.79%	-23.33%	-
Enterprise Value	288,609	332,302	335,404	170,199	147,414	284,398
Last Close Price	22600.00	24660.94	24749.42	18879.37	26565.12	24861.10
PE Ratio	24.03	21.16	28.53	40.94	50.11	10.03
PS Ratio	0.78	0.73	0.83	0.65	0.55	0.47
PB Ratio	0.87	0.98	1.02	0.81	1.13	1.35
P/TBV Ratio	0.87	0.98	1.02	0.81	1.13	1.35
P/FCF Ratio	-	8.57	-	-	24.24	4.05
P/OCF Ratio	-	6.77	-	9.94	3.02	2.74
EV/Sales Ratio	0.80	0.75	0.83	0.42	0.43	0.55
EV/EBITDA Ratio	11.58	11.04	14.83	9.12	8.00	7.64
EV/EBIT Ratio	16.75	14.97	23.65	19.71	16.58	10.45
EV/FCF Ratio	-	8.82	-	-	19.03	4.70
Debt / Equity Ratio	0.14	0.08	0.20	0.28	0.41	0.44
Debt / EBITDA Ratio	1.78	0.92	2.85	4.87	3.72	2.16
Debt / FCF Ratio	-	0.74	-	-	8.86	1.33
Asset Turnover	0.65	0.84	0.64	0.67	0.68	0.96
Inventory Turnover	2.91	3.68	3.12	3.38	3.05	3.60
Quick Ratio	0.54	0.73	0.69	0.83	0.70	0.87
Current Ratio	1.41	1.46	1.32	1.22	1.04	1.21
Return on Equity (ROE)	3.55%	4.63%	3.62%	2.61%	2.16%	13.93%
Return on Assets (ROA)	1.94%	2.62%	1.41%	0.91%	1.09%	3.12%
Return on Capital (ROIC)	2.73%	3.70%	2.20%	1.67%	2.24%	6.46%
Return on Capital Employed (ROCE)	5.40%	6.70%	4.30%	2.70%	5.40%	15.00%
Earnings Yield	4.16%	4.72%	3.50%	2.44%	2.00%	9.97%
FCF Yield	-	11.68%	-25.22%	-34.93%	4.13%	24.71%
Dividend Yield	3.98%	-	3.64%	2.65%	0.94%	-
Payout Ratio	-	72.28%	54.72%	138.49%	354.43%	38.11%
Buyback Yield / Dilution	5.83%	-	-32.18%	-49.59%	0.05%	0.01%
Total Shareholder Return	9.82%	-	-28.54%	-46.94%	0.99%	0.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.